Digital Pharmacy Market

Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) - Global Forecasts to 2027

Report Code: HIT 8116 Jun, 2022, by marketsandmarkets.com

[224 Pages Report] The digital pharmacy market is projected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period. The growth of this market is driven by the increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic, consolidation in the market and partnerships, and the growing geriatric population.

However, patients relying on pharmacists for clinical support and a growing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period.

Digital Pharmacy Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Digital Pharmacy Market

The increasing number of internet users, growing access to online services, and the rising implementation of e-prescriptions in healthcare services in the wake of the COVID-19 pandemic are other key factors supporting market growth. CVS Health began to employ new measures to balance the requirement of drugs used in the treatment of both COVID-19 and other chronic diseases in March 2020. Amazon launched an online pharmacy service in the US for both generic and prescription medications in November 2020. In pre-COVID times, 70% of households were chronic-first users of digital pharmacy as they found better value in these reasonable & convenient services. However, during the lockdown phase, an equal proportion of chronic-first and acute-first households were onboarded, as digital pharmacy became the need of the hour.Additionally, the growth of the market is also supported by the increased demand for over-the-counter products, such as masks, sanitizers, thermometers, and steamers, among others. Thus, the fast adoption of over-the-counter (OTC) products will positively impact the market.

Digital Pharmacy Market Dynamics

How growth of consumer preference towards buying online medicines increased during and the post COVID-19 ?

COVID-19 is one of the leading social and health challenges of our time. The ongoing pandemic has forced a drastic transformation of life—at every level of society. The high infection rate of COVID-19 led to an increased demand for medication in hospitals and home care settings. COVID-19 has changed the way in which businesses are conducted. Consumer attitudes, behaviors, and purchasing habits have all changed—and many of these new patterns will remain post-pandemic. Nationwide lockdowns during the pandemic forced people to stay indoors. This pushed people to switch to online channels for the purchase of goods & services as well as to pay bills and consult with doctors. According to the FICCI 2020 report, more than 75% of all consumers cited that their online pharmacy purchases either increased or remained the same. This changing consumer behavior is expected to drive the market for digital pharmacy solutions in the coming years.

How is growing illegal pharmacies restraining growth of the market?

Illegal internet pharmacies are often international operations with servers, shipping operations, and other parts of the business located in several countries. The WHO emphasizes that substandard and falsified products may result in patient harm and suboptimal treatment, leading to an overall mistrust of medications, healthcare providers, and the health system. In 2021, the FDA issued warning letters to website operators engaged in illegal activity in violation of the US Federal Food, Drug, and Cosmetic Act. Consumers seeking overseas options to obtain medicines also pose a threat to the pharmaceutical industry and pharmacists of the respective country. Such illegal buying behaviors can result in the loss of credibility and faith in online medicine and may hinder the greater adoption of digital pharmacy solutions globally

Why is lack of strong national laws worldwide a critical challenging factor that is holding back growth of market?

According to the International Society for Pharmaceutical Engineering 2019, 66% of countries worldwide do not have laws that explicitly regulate or prohibit the online sales of medicinal products. As a result, regulatory authorities in these countries are only able to employ the “buyers beware” approach so that consumers remain vigilant when buying medicinal products online. The Federal Bureau of Investigation (FBI) estimated that there are more than 80,000 websites that allow individuals to place medication orders through illegal pharmacies. Customers choose to utilize online pharmacies over traditional brick-and-mortar pharmacies for a variety of reasons, including accessibility, time constraints, and potential cost savings. In Nigeria, the body responsible for licensing pharmacies, the Pharmacy Council of Nigeria, has developed rules to guide the regulatory process for e-pharmacies in 2016, but they have not yet been made public. Until an international legal framework is formed and agreed upon, illegal pharmacies will continue to expand and inappropriately dispense medications to consumers. This may hinder the growth of the digital pharmacy market in low-income and middle-income countries (LMICs).

What opportunities does increase in the emerging market?

Emerging economies are expected to become a focal point for growth in the digital pharmacy market. Developing countries possess a high geriatric population. In China, the population of individuals aged 65 years and above was estimated to be 131.4 million in 2015 and was expected to grow by 29.0% to reach 169.6 million by 2020 (Source: The United Nations Population Division Statistics). As the elderly are more susceptible to diseases, the rising geriatric population is expected to drive patient volumes in several countries across the globe. This, in turn, will increase the demand for digital pharmacy solutions. The developing economies, growing government support, rising life science research, and improving healthcare infrastructure in China, Korea, and India also compel pharmacies in these countries to opt for online platforms. Due to these factors, major players are investing in the Asia Pacific region.

North America accounted for the largest share of the digital pharmacy market in 2021.

North America accounted for the largest share of the market. The increasing prevalence of chronic conditions, the rising number of drug prescriptions resulting from the rapidly growing aging population, and the presence of key market players in the region are the key factors driving the growth of the market in North America.

Digital Pharmacy Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Some of the key players are CVS Health (US), Cigna (US), Optum, Inc. (Part of the UnitedHealth Group) (US), Walgreens Co. (US), Walmart Inc. (US), The Kroger Co. (US), Amazon.com, Inc. (US), GoodRx (US), Costco Wholesale Corporation (US), Rite Aid Corp. (US), Hims & Hers Health, Inc. (US), PharmEasy (India), Apollo Pharmacy (India), DocMorris (Netherlands), Giant Eagle Inc. (US), LloydsPharmacy (UK), Shop-apotheke.com (Netherlands), Tata 1mg (India), Netmeds.com (India), HealthWarehouse, Inc. (US), Pharmex Direct Inc. (Canada), Apex Pharmacy (UK), TELUS (Canada), RO Pharmacy (US), Rx Outreach (US), The Independent Pharmacy (UK), Rexall Pharmacy Group ULC (Canada), and NorthWestPharmacy.com (Canada). These players are increasingly focusing on product/service upgrades, acquisitions, partnerships, agreements, expansions, and collaborations to expand their product offerings in the digital pharmacy market

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020-2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD Billion)

Segments covered

Drug Type, Products, Platform, Business Model, Geographic Coverage,And Region

Geographies covered

North America (US, and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), Latin America and Middle East & Africa

Companies covered

CVS Health (US), Cigna (US), Optum, Inc. (Part of the UnitedHealth Group) (US), Walgreen Co. (US), Walmart Inc. (US), The Kroger Co. (US), Amazon.com, Inc. (US), GoodRx (US), Costco Wholesale Corporation (US), Rite Aid Corp. (US), Hims & Hers Health, Inc. (US), PharmEasy (India), Apollo Pharmacy (India), DocMorris (Netherlands), Giant Eagle Inc. (US), LloydsPharmacy (UK), Shop-apotheke.com (Netherlands), Tata 1mg (India), Netmeds.com (India), HealthWarehouse, Inc. (US), Pharmex Direct Inc. (Canada), Apex Pharmacy (UK), TELUS (Canada), Ro Pharmacy (US), Rx Outreach (US), The Independent Pharmacy (UK), Rexall Pharmacy Group ULC (Canada), and NorthWestPharmacy.com (Canada).

The study categorizes the Digital Pharmacy market into the following segments and subsegments:

Digital pharmacy market, By drug type

  • Prescription Medicines
  • Over-the-counter products

Digital pharmacy market, By Products

  • Medicines & Treatments,By Type
  • Personal Care Products
  • Vitamins & Supplements
  • Other Products

Digital pharmacy market, by Platform

  • Apps
  • Websites

Digital pharmacy market, By Business Model

  • Captive
  • Franchise
  • Aggregator

Digital pharmacy market, By Geographic Coverage

  • Urban Areas
  • Rural Areas

Digital pharmacy market, By Region,

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments:

  • In 2021, Walgreens Co. (US) launched nationwide contactless same-day delivery services (in under two hours) for more than 24,000 products.
  • In 2021, Rite Aid Corp. (US) partnered with Uber to deliver Rite Aid products nationwide through Uber Eats, allowing customers to conveniently order and receive essential healthcare and grocery items directly to their homes.
  • In 2021, PharmEasy (India) acquired Medlife to become the largest healthcare delivery platform in India.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 DIGITAL PHARMACY MARKET: INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 DIGITAL PHARMACY MARKET
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
           1.5.1 SCOPE-RELATED LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 30)
    2.1 RESEARCH DATA
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                    2.1.2.1 Key industry insights
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET ESTIMATION
           2.2.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
           2.2.2 APPROACH: REVENUE MAPPING-BASED MARKET ESTIMATION
                    FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
                    FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
                    FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION FOR CVS HEALTH
           2.2.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
                    FIGURE 7 DIGITAL PHARMACY MARKET: TOP-DOWN APPROACH
           2.2.4 GROWTH FORECAST
                    FIGURE 8 IMPACT OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES ON MARKET GROWTH & CAGR
                    FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.3 MARKET DATA ESTIMATION AND TRIANGULATION
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.4 ASSUMPTIONS FOR THE STUDY
    2.5 LIMITATIONS
    2.6 RISK ASSESSMENT
          TABLE 1 RISK ASSESSMENT: DIGITAL PHARMACY MARKET

3 EXECUTIVE SUMMARY (Page No. - 43)
    FIGURE 11 DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 MARKET, BY PLATFORM, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 MARKET, BY BUSINESS MODEL, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 MARKET, BY GEOGRAPHIC COVERAGE, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PHARMACY MARKET

4 PREMIUM INSIGHTS (Page No. - 48)
    4.1 DIGITAL PHARMACY MARKET OVERVIEW
          FIGURE 17 GROWING GERIATRIC POPULATION TO DRIVE THE MARKET GROWTH
    4.2 MARKET, BY PRODUCT
          FIGURE 18 MEDICINES & TREATMENTS ACCOUNTED FOR THE LARGEST SHARE OF THE DIGITAL PHARMACY MARKET IN 2021
    4.3 NORTH AMERICA: MARKET, BY DRUG & COUNTRY (2021)
          FIGURE 19 PRESCRIPTION MEDICINES ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2021
    4.4 GEOGRAPHICAL SNAPSHOT OF THE MARKET
          FIGURE 20 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
    4.5 MARKET DYNAMICS
          FIGURE 21 DIGITAL PHARMACY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
           4.5.1 DRIVERS
                    4.5.1.1 Increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic
                                TABLE 2 TOTAL NUMBER OF CONFIRMED CORONAVIRUS CASES, BY REGION (AS OF JANUARY 7, 2022)
                    4.5.1.2 Consolidation in the market and partnerships
                    4.5.1.3 Growing geriatric population
                                TABLE 3 GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION)
           4.5.2 RESTRAINTS
                    4.5.2.1 Growing number of illegal pharmacies
                    4.5.2.2 Risk of counterfeit drugs
                    4.5.2.3 Increased risk of drug abuse
           4.5.3 OPPORTUNITIES
                    4.5.3.1 Emerging markets
                    4.5.3.2 Benefits of E-commerce
           4.5.4 CHALLENGES
                    4.5.4.1 Challenges for patients relying on pharmacists for clinical support
                    4.5.4.2 Lack of strong national laws worldwide
                    4.5.4.3 Security and privacy concerns
    4.6 VALUE CHAIN ANALYSIS
    4.7 ECOSYSTEM ANALYSIS
    4.8 PORTER’S FIVE FORCES ANALYSIS
          TABLE 4 DIGITAL PHARMACY MARKET: PORTER’S FIVE FORCES ANALYSIS
           4.8.1 INTENSITY OF COMPETITIVE RIVALRY
           4.8.2 BARGAINING POWER OF SUPPLIERS
           4.8.3 BARGAINING POWER OF BUYERS
           4.8.4 THREAT FROM SUBSTITUTES
           4.8.5 THREAT FROM NEW ENTRANTS
    4.9 PRICING & REIMBURSEMENT ANALYSIS
          5 COMPARISON OF AVERAGE DISCOUNTED PRICES FOR A ONE-MONTH SUPPLY OF DRUGS
    4.10 TECHNOLOGY ANALYSIS
           4.10.1 MACHINE LEARNING
           4.10.2 INTERNET OF THINGS
           4.10.3 BLOCKCHAIN
           4.10.4 CLOUD COMPUTING
    4.11 INDUSTRY TRENDS
           4.11.1 ONLINE PRESCRIPTION REFILL
           4.11.2 VIRTUAL HEALTHCARE SERVICES
           4.11.3 DIGITAL HEALTH DIAGNOSTIC TOOLS
    4.12 KEY CONFERENCES & EVENTS IN 2021–2022
    4.13 REGULATORY ANALYSIS
           4.13.1 NORTH AMERICA
                    4.13.1.1 US
                    4.13.1.2 Canada
           4.13.2 EUROPE
           4.13.3 ASIA PACIFIC
           4.13.4 REST OF THE WORLD
                     TABLE 6 APPROACHES OF REGULATORY AUTHORITIES (RA) WORLDWIDE TO CONTROL MEDICINAL PRODUCT ONLINE SALES
    4.14 CASE STUDIES
           4.14.1 MAGENTO 2 WEB APP MODERNIZATION
                    4.14.1.1 Use Case 1: Need to Revamp Online Store
           4.14.2 WALMART REACT NATIVE PHARMACY
                    4.14.2.1 Use Case 2: Need to Rebuild Pharmacy App
    4.15 IMPACT OF COVID-19 ON THE DIGITAL PHARMACY MARKET

5 DIGITAL PHARMACY MARKET, BY DRUG TYPE (Page No. - 70)
    5.1 INTRODUCTION
          TABLE 7 MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
    5.2 PRESCRIPTION MEDICINES
           5.2.1 GROWING GERIATRIC POPULATION AND SUBSEQUENT INCREASE IN CHRONIC DISEASES TO DRIVE THE DEMAND FOR PRESCRIPTION MEDICATION
                      TABLE 8 MARKET FOR PRESCRIPTION MEDICINES, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 9 NORTH AMERICA: MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 10 EUROPE: MARKET FOR PRESCRIPTION MEDICINES, BY COUNTRY, 2020–2027 (USD MILLION)
    5.3 OVER-THE-COUNTER PRODUCTS
           5.3.1 EASE OF USE AND CONVENIENCE ASSOCIATED WITH OVER-THE-COUNTER PRODUCTS TO DRIVE MARKET GROWTH
                      TABLE 11 MARKET FOR OVER-THE-COUNTER PRODUCTS, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 12 NORTH AMERICA: DIGITAL PHARMACY MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 13 EUROPE: MARKET FOR OVER-THE-COUNTER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)

6 DIGITAL PHARMACY MARKET, BY PRODUCT (Page No. - 76)
    6.1 INTRODUCTION
          TABLE 14 MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 MEDICINES & TREATMENTS
          TABLE 15 MARKET FOR MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 16 NORTH AMERICA: MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 17 EUROPE: MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 18 ASIA PACIFIC: MARKET FOR MEDICINES & TREATMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 19 MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
           6.2.1 DIABETES CARE
                    6.2.1.1 Growing global diabetic population will ensure strong demand for diabetes care medicines & treatments
                                TABLE 20 MARKET FOR DIABETES CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
           6.2.2 HEART CARE
                    6.2.2.1 Rising incidence of cardiovascular diseases drives the demand for heart care medicines & treatments
                                TABLE 21 DIGITAL PHARMACY MARKET FOR HEART CARE MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
           6.2.3 ONCOLOGY
                    6.2.3.1 Increasing prevalence of cancer is a major factor driving the growth of this market segment
                                TABLE 22 MARKET FOR ONCOLOGY MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
                    6.2.3.2 Other medicines & treatments
                                TABLE 23 MARKET FOR OTHER MEDICINES & TREATMENTS, BY REGION, 2020–2027 (USD MILLION)
    6.3 PERSONAL CARE PRODUCTS
           6.3.1 GROWING FOCUS ON PERSONAL HEALTH & HYGIENE TO DRIVE MARKET GROWTH
                      TABLE 24 DIGITAL PHARMACY MARKET FOR PERSONAL CARE PRODUCTS, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 25 NORTH AMERICA: MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 26 EUROPE: MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 27 ASIA PACIFIC: MARKET FOR PERSONAL CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.4 VITAMINS & SUPPLEMENTS
           6.4.1 GROWING DEMAND FOR IMMUNITY-ASSOCIATED SUPPLEMENTS IN THE WAKE OF THE COVID-19 PANDEMIC TO DRIVE MARKET GROWTH
                      TABLE 28 DIGITAL PHARMACY MARKET FOR VITAMINS & SUPPLEMENTS, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 29 NORTH AMERICA: MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 30 EUROPE: MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 31 ASIA PACIFIC: MARKET FOR VITAMINS & SUPPLEMENTS, BY COUNTRY, 2020–2027 (USD MILLION)
    6.5 OTHER PRODUCTS
                   TABLE 32 DIGITAL PHARMACY MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 33 NORTH AMERICA: MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 34 EUROPE: MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 35 ASIA PACIFIC: MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION)

7 DIGITAL PHARMACY MARKET, BY PLATFORM (Page No. - 88)
    7.1 INTRODUCTION
          TABLE 36 MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
    7.2 APPS
           7.2.1 ADVANTAGES SUCH AS CONTACTLESS DELIVERY WILL DRIVE THE DEMAND FOR APPS
                      TABLE 37 DIGITAL PHARMACY APPS MARKET, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 38 NORTH AMERICA: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 39 EUROPE: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 40 ASIA PACIFIC: DIGITAL PHARMACY APPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 WEBSITES
           7.3.1 PROMOTIONS, DISCOUNTS, AND OFFERS PROVIDED BY WEBSITES TO DRIVE MARKET GROWTH
                      TABLE 41 DIGITAL PHARMACY WEBSITES MARKET, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 42 NORTH AMERICA: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 43 EUROPE: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 44 ASIA PACIFIC: DIGITAL PHARMACY WEBSITES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

8 DIGITAL PHARMACY MARKET, BY BUSINESS MODEL (Page No. - 94)
    8.1 INTRODUCTION
          TABLE 45 MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
    8.2 CAPTIVE
           8.2.1 FLEXIBILITY, ACCESSIBILITY, AND AFFORDABILITY OF CAPTIVE MODELS—KEY FACTORS DRIVING MARKET GROWTH
                      TABLE 46 MARKET FOR CAPTIVE MODELS, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 47 NORTH AMERICA: MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 48 EUROPE: MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 49 ASIA PACIFIC: MARKET FOR CAPTIVE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 FRANCHISE
           8.3.1 GROWING NUMBER OF PHARMACY FRANCHISES TO DRIVE MARKET GROWTH
                      TABLE 50 MARKET FOR FRANCHISE MODELS, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 51 NORTH AMERICA: MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 52 EUROPE: MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 53 ASIA PACIFIC: MARKET FOR FRANCHISE MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 AGGREGATOR
           8.4.1 QUALITY SERVICES ASSOCIATED WITH AGGREGATOR MODELS TO DRIVE MARKET GROWTH
                      TABLE 54 MARKET FOR AGGREGATOR MODELS, BY REGION, 2020–2027 (USD MILLION)
                      TABLE 55 NORTH AMERICA: MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 56 EUROPE: MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION)
                      TABLE 57 ASIA PACIFIC: MARKET FOR AGGREGATOR MODELS, BY COUNTRY, 2020–2027 (USD MILLION)

9 DIGITAL PHARMACY MARKET, BY GEOGRAPHIC COVERAGE (Page No. - 102)
    9.1 INTRODUCTION
           TABLE 58 MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
    9.2 URBAN AREAS
           9.2.1 RAPID INTERNET PENETRATION IN URBAN AREAS TO DRIVE MARKET GROWTH IN THIS SEGMENT
                      TABLE 59 MARKET IN URBAN AREAS, BY REGION, 2020–2027 (USD MILLION)
    9.3 RURAL AREAS
           9.3.1 GOVERNMENT INITIATIVES TO FUEL THE DEMAND FOR DIGITAL PHARMACIES IN RURAL AREAS
                      TABLE 60 MARKET IN RURAL AREAS, BY REGION, 2020–2027 (USD MILLION)

10 DIGITAL PHARMACY MARKET, BY REGION (Page No. - 106)
     10.1 INTRODUCTION
            TABLE 61 MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.2 NORTH AMERICA
             10.2.1 IMPACT OF COVID-19 ON THE NORTH AMERICAN MARKET
                        FIGURE 22 NORTH AMERICA: MARKET SNAPSHOT
                        TABLE 62 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 63 NORTH AMERICA: MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                        TABLE 64 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 65 NORTH AMERICA: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 66 NORTH AMERICA: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                        TABLE 67 NORTH AMERICA: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
                        TABLE 68 NORTH AMERICA: MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
             10.2.2 US
                        10.2.2.1 The US is the largest regional market for digital pharmacy, mainly due to the rising prevalence of chronic conditions and the growing number of prescriptions
                                      TABLE 69 US: KEY MACROINDICATORS
                                      TABLE 70 US: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 71 US: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 72 US: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 73 US: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 74 US: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
                                      TABLE 75 US: MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
             10.2.3 CANADA
                        10.2.3.1 Rising drug expenditures to propel market growth in Canada
                                      TABLE 76 CANADA: KEY MACROINDICATORS
                                      TABLE 77 CANADA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 78 CANADA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 79 CANADA: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 80 CANADA: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 81 CANADA: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
                                      TABLE 82 CANADA: MARKET, BY GEOGRAPHIC COVERAGE, 2020–2027 (USD MILLION)
     10.3 EUROPE
             10.3.1 IMPACT OF COVID-19 ON THE EUROPEAN DIGITAL PHARMACY MARKET
                        TABLE 83 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 84 EUROPE: MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                        TABLE 85 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 86 EUROPE: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 87 EUROPE: MARKET, BY PLATFORM,  2020–2027 (USD MILLION)
                        TABLE 88 EUROPE: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.3.2 GERMANY
                        10.3.2.1 Germany is the fastest-growing market for digital pharmacies in Europe
                                      TABLE 89 GERMANY: KEY MACROINDICATORS
                                      TABLE 90 GERMANY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 91 GERMANY: MARKET, BY PRODUCT,  2020–2027 (USD MILLION)
                                      TABLE 92 GERMANY: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 93 GERMANY: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 94 GERMANY: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.3.3 UK
                        10.3.3.1 Rising initiatives to improve the safety of digital pharmacies to boost the market growth
                                      TABLE 95 UK: KEY MACROINDICATORS
                                      TABLE 96 UK: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 97 UK: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 98 UK: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 99 UK: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 100 UK: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.3.4 FRANCE
                        10.3.4.1 Rising geriatric population in the country to support market growth
                                      TABLE 101 FRANCE: KEY MACROINDICATORS
                                      TABLE 102 FRANCE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 103 FRANCE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 104 FRANCE: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 105 FRANCE: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 106 FRANCE: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.3.5 ITALY
                        10.3.5.1 Growing burden of chronic diseases is driving the market growth in Italy
                                      TABLE 107 ITALY: KEY MACROINDICATORS
                                      TABLE 108 ITALY: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 109 ITALY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 110 ITALY: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 111 ITALY: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 112 ITALY: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.3.6 SPAIN
                        10.3.6.1 Increasing focus on improving the healthcare infrastructure in the country to support market growth
                                      TABLE 113 SPAIN: KEY MACROINDICATORS
                                      TABLE 114 SPAIN: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 115 SPAIN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 116 SPAIN: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 117 SPAIN: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 118 SPAIN: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.3.7 ROE
                        TABLE 119 ROE: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                        TABLE 120 ROE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 121 ROE: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 122 ROE: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                        TABLE 123 ROE: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
     10.4 ASIA PACIFIC
             10.4.1 IMPACT OF COVID-19 ON THE ASIA PACIFIC DIGITAL PHARMACY MARKET
                        FIGURE 23 ASIA PACIFIC: MARKET SNAPSHOT
                        TABLE 124 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                        TABLE 125 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 126 ASIA PACIFIC: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                        TABLE 127 ASIA PACIFIC: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Increasing consumer demand for OTC products to drive the market for digital pharmacy in China
                                      TABLE 128 CHINA: KEY MACROINDICATORS
                                      TABLE 129 CHINA: DIGITAL PHARMACY MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 130 CHINA: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 131 CHINA: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Rising healthcare expenditures and the growing burden of non-communicable diseases (NCDs) to drive market growth in Japan
                                      TABLE 132 JAPAN: KEY MACROINDICATORS
                                      TABLE 133 JAPAN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 134 JAPAN: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 135 JAPAN: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 Favorable government initiatives and high density of rural population to support market growth in India
                                      TABLE 136 INDIA: KEY MACROINDICATORS
                                      TABLE 137 INDIA: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 138 INDIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 139 INDIA: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 140 INDIA: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 141 INDIA: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
             10.4.5 REST OF ASIA PACIFIC
                        TABLE 142 ROAPAC: DIGITAL PHARMACY MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                        TABLE 143 ROAPAC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 144 ROAPAC: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                        TABLE 145 ROAPAC: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
     10.5 LATIN AMERICA
             10.5.1 GROWING INTERNET USERS WILL FAVOR MARKET GROWTH IN LATAM
                        10.5.1.1 Impact of COVID-19 on the Latin American digital pharmacy market
                                      TABLE 146 LATIN AMERICA: KEY MACROINDICATORS
                                      TABLE 147 LATIN AMERICA: MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 148 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 149 LATIN AMERICA: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 150 LATIN AMERICA: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 151 LATIN AMERICA: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA
             10.6.1 INCREASING DEMAND FOR ONLINE PHARMACEUTICAL PRODUCTS WILL DRIVE THE MARKET IN THE MEA
                        10.6.1.1 Impact of COVID-19 on the Middle East & Africa digital pharmacy market
                                      TABLE 152 MEA: MARKET, BY DRUG TYPE, 2020–2027 (USD MILLION)
                                      TABLE 153 MEA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                      TABLE 154 MEA: MARKET FOR MEDICINES & TREATMENTS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 155 MEA: MARKET, BY PLATFORM, 2020–2027 (USD MILLION)
                                      TABLE 156 MEA: MARKET, BY BUSINESS MODEL, 2020–2027 (USD MILLION)

11 COMPETITIVE LANDSCAPE (Page No. - 154)
     11.1 OVERVIEW
     11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE DIGITAL PHARMACY MARKET
     11.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
     11.4 MARKET RANKING
            FIGURE 24 US DIGITAL PHARMACY MARKET RANKING, BY KEY PLAYER, 2021
     11.5 COMPETITIVE BENCHMARKING
             11.5.1 OVERALL COMPANY FOOTPRINT
                        TABLE 157 OVERALL COMPANY FOOTPRINT
             11.5.2 COMPANY DRUG TYPE FOOTPRINT
                        TABLE 158 COMPANY DRUG TYPE FOOTPRINT
             11.5.3 COMPANY PRODUCT FOOTPRINT
                        TABLE 159 COMPANY PRODUCT FOOTPRINT
             11.5.4 COMPANY PLATFORM FOOTPRINT
                        TABLE 160 COMPANY PLATFORM FOOTPRINT
             11.5.5 COMPANY REGIONAL FOOTPRINT
                        TABLE 161 COMPANY REGIONAL FOOTPRINT
                        TABLE 162 DIGITAL PHARMACY MARKET: DETAILED LIST OF KEY START-UPS/SMES
     11.6 COMPETITIVE LEADERSHIP MAPPING
             11.6.1 STARS
             11.6.2 EMERGING LEADERS
             11.6.3 PERVASIVE PLAYERS
             11.6.4 PARTICIPANTS
                        FIGURE 25 DIGITAL PHARMACY MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
     11.7 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES
             11.7.1 PROGRESSIVE COMPANIES
             11.7.2 STARTING BLOCKS
             11.7.3 RESPONSIVE COMPANIES
             11.7.4 DYNAMIC COMPANIES
                        FIGURE 26 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME MATRIX MARKET
     11.8 COMPETITIVE SITUATIONS AND TRENDS
             11.8.1 PRODUCT/SERVICE UPGRADES
             11.8.2 DEALS
             11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES (Page No. - 167)
     12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
             12.1.1 CVS HEALTH
                        TABLE 163 CVS HEALTH: BUSINESS OVERVIEW
                        FIGURE 27 CVS HEALTH: COMPANY SNAPSHOT (2021)
             12.1.2 CIGNA
                        TABLE 164 CIGNA: BUSINESS OVERVIEW
                        FIGURE 28 CIGNA: COMPANY SNAPSHOT (2021)
             12.1.3 OPTUM, INC. (PART OF THE UNITEDHEALTH GROUP)
                        TABLE 165 OPTUM, INC.: BUSINESS OVERVIEW
                        FIGURE 29 OPTUM, INC.: COMPANY SNAPSHOT (2021)
             12.1.4 WALGREEN CO.
                        TABLE 166 WALGREEN CO.: BUSINESS OVERVIEW
                        FIGURE 30 WALGREEN CO.: COMPANY SNAPSHOT (2021)
             12.1.5 WALMART INC.
                        TABLE 167 WALMART INC.: BUSINESS OVERVIEW
                        FIGURE 31 WALMART INC.: COMPANY SNAPSHOT (2021)
             12.1.6 THE KROGER CO.
                        TABLE 168 THE KROGER CO.: BUSINESS OVERVIEW
                        FIGURE 32 THE KROGER CO.: COMPANY SNAPSHOT (2020)
             12.1.7 GIANT EAGLE, INC.
                        TABLE 169 GIANT EAGLE, INC.: BUSINESS OVERVIEW
             12.1.8 AMAZON.COM, INC.
                        TABLE 170 AMAZON.COM, INC.: BUSINESS OVERVIEW
                        FIGURE 33 AMAZON.COM, INC.: COMPANY SNAPSHOT (2020)
             12.1.9 PHARMEASY
                        TABLE 171 PHARMEASY: BUSINESS OVERVIEW
             12.1.10 APEX PHARMACY
                        TABLE 172 APEX PHARMACY: BUSINESS OVERVIEW
             12.1.11 APOLLO PHARMACY
                        TABLE 173 APOLLO PHARMACY: BUSINESS OVERVIEW
                        FIGURE 34 APOLLO HOSPITAL: COMPANY SNAPSHOT (2021)
             12.1.12 RITE AID CORP
                        TABLE 174 RITE AID CORP.: BUSINESS OVERVIEW
                        FIGURE 35 RITE AID CORP.: COMPANY SNAPSHOT (2021)
             12.1.13 COSTCO WHOLESALE CORPORATION
                        TABLE 175 COSTCO WHOLESALE CORPORATION: BUSINESS OVERVIEW
                        FIGURE 36 COSTCO WHOLESALE CORPORATION: COMPANY SNAPSHOT (2021)
     12.2 SHOP-APOTHEKE.COM
             12.2.1 NETMEDS.COM
             12.2.2 DOCMORRIS
             12.2.3 TATA 1MG
             12.2.4 LLOYDSPHARMACY
             12.2.5 GOODRX, INC.
             12.2.6 HEALTHWAREHOUSE.COM
             12.2.7 TELUS HEALTH
             12.2.8 PHARMEX DIRECT INC.
             12.2.9 HIMS & HERS HEALTH, INC.
             12.2.10 RO PHARMACY
             12.2.11 RX OUTREACH
             12.2.12 THE INDEPENDENT PHARMACY
             12.2.13 REXALL PHARMACY GROUP ULC
             12.2.14 NORTHWESTPHARMACY.COM

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX (Page No. - 217)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Digital Pharmacy market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the digital pharmacy market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as WHO, AMA,CDC and HIMSS. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global digital pharmacy market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global digital pharmacy market scenario through secondary research. Several primary interviews were conducted with market experts from supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. The primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Digital Pharmacy Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Both top-down and bottom-up approaches were used to estimate to estimate and validate the size of the global digital pharmacy market and various dependent submarkets .The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The revenue generated from the sale of digital pharmacy products by leading players has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the digital pharmacy market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from supply sides in the digital pharmacy market.

Report Objectives

  • To define, describe, segment, analyze, and forecast the digital pharmacy market based on drug type, product, platform, business model, geographic coverage, and region
  • To provide detailed information regarding the drivers, restraints, opportunities, challenges, and industry trends influencing the growth of the digital pharmacy market
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the digital pharmacy for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the global digital pharmacy market with respect to five main regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as product/service upgrades, acquisitions, partnerships, agreements, expansions, and collaborations in the digital pharmacy market during the forecast period

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company information

  • Detailed analysis and profiling of additional market players (up to 20)
Report Code
HIT 8116
Published ON
Jun, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Digital Pharmacy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback